A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
It’s the latest in several moves — announced in swift succession — that suggest a radical overhaul in Zuckerberg’s thinking about Meta.
Executives at top financial services firms expect to cut as many 200,000 jobs in the next five years and significantly increase revenues.
The investment company says advisors and investors should break from the traditional strategy and take on more defensive positions this year.